Ruochuan K. Zang
Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, 100021, China
Beijing, 100021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Decoding the SHOX2 methylation-expression paradox in lung adenocarcinoma: Dual-regulatory methylation patterns drive oncogenic activation and prognostic relevance.
Journal: Cancer letters
Published: September 06, 2025
Utility of 18F-FDG uptake in predicting major pathological response to neoadjuvant immunotherapy in patients with resectable non‑small cell lung cancer.
Journal: Translational oncology
Published: February 20, 2023
Association between radiotherapy and risk of second primary malignancies in patients with resectable lung cancer: a population-based study.
Journal: Journal of translational medicine
Published: September 18, 2022
Multimodal analysis of cell-free DNA whole-methylome sequencing for cancer detection and localization.
Journal: Nature communications
Published: August 29, 2022
Global burden and temporal trends in incidence and mortality of oesophageal cancer.
Journal: Journal of advanced research
Published: August 06, 2022
RNA modification writer expression profiles predict clinical outcomes and guide neoadjuvant immunotherapy in non-small cell lung cancer.
Journal: EBioMedicine
Published: May 31, 2022
Identifying novel tumor-related antigens and immune phenotypes for developing mRNA vaccines in lung adenocarcinoma.
Journal: International immunopharmacology
Published: January 29, 2022
A new N descriptor for non-small cell lung cancer: the classification based on anatomic location, number and ratio of metastatic lymph nodes.
Journal: Translational lung cancer research
Published: November 24, 2021
Comprehensive analysis of PD-L1 expression, tumor-infiltrating lymphocytes, and tumor microenvironment in LUAD: differences between Asians and Caucasians.
Journal: Clinical epigenetics
Published: November 08, 2021
Research Progress of Anti-PD-1/PD-L1 Immunotherapy Related Mechanisms and Predictive Biomarkers in NSCLC.
Journal: Frontiers in oncology
Published: September 01, 2021
Consolidation Tumor Ratio Combined With Pathological Features Could Predict Status of Lymph Nodes of Early-Stage Lung Adenocarcinoma.
Journal: Frontiers in oncology
Published: July 29, 2021
Last Updated: 09/26/2026